215 related articles for article (PubMed ID: 31876714)
1. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report.
Liu Q; Wei J; Liu X; Wang J
Medicine (Baltimore); 2019 Dec; 98(52):e18414. PubMed ID: 31876714
[TBL] [Abstract][Full Text] [Related]
2. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.
Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T
Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: An unusual histomorphology and behavior.
Sethi B; Pai T; Allam A; Epari S
Indian J Pathol Microbiol; 2015; 58(4):509-12. PubMed ID: 26549078
[TBL] [Abstract][Full Text] [Related]
4. [Case of an Inflammatory Myofibroblastic Tumor of the Duodenum].
Park SG; Kim GH; Park HJ; Kahng DH; Lee BE; Park DY
Korean J Gastroenterol; 2018 Jul; 72(1):28-32. PubMed ID: 30049175
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement.
Rafee S; Elamin YY; Joyce E; Toner M; Flavin R; McDermott R; Sheehy N; Hennessy B; O'Byrne K; Gleeson N; Osman N
Tumori; 2015 Apr; 101(2):e35-9. PubMed ID: 25744866
[TBL] [Abstract][Full Text] [Related]
6. Bilateral multiple inflammatory myofibroblastic tumors of the lung successfully treated with corticosteroids.
Lee MH; Lee HB; Lee YC; Rhee YK; Lee EJ; Chung MJ; Jin GY; Kweon EY; Park SJ
Lung; 2011 Oct; 189(5):433-5. PubMed ID: 21809057
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B
Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187
[TBL] [Abstract][Full Text] [Related]
8. ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
Wang K; Zhou H; Lu Y; Lu Q; Zhang C; Zhou X; Xia S; Wang G
Medicine (Baltimore); 2018 Dec; 97(51):e13619. PubMed ID: 30572472
[TBL] [Abstract][Full Text] [Related]
9. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
Brivio E; Zwaan CM
Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
[TBL] [Abstract][Full Text] [Related]
10. "How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor".
Albayrak HC; Gürler F; Sütçüoğlu O; Akyürek N; Özet A
Anticancer Drugs; 2022 Jan; 33(1):109-111. PubMed ID: 34261914
[TBL] [Abstract][Full Text] [Related]
11. ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.
Fan J; Huang B; Yang X; Yang M; He J; Nie X
Diagn Pathol; 2017 Sep; 12(1):68. PubMed ID: 28923119
[TBL] [Abstract][Full Text] [Related]
12. Complete and Repeated Response of a Metastatic ALK-rearranged Inflammatory Myofibroblastic Tumor to Crizotinib in a Teenage Girl.
Gaudichon J; Jeanne-Pasquier C; Deparis M; Veyssière A; Heyndrickx M; Minckes O; Orbach D
J Pediatr Hematol Oncol; 2016 May; 38(4):308-11. PubMed ID: 26808369
[TBL] [Abstract][Full Text] [Related]
13. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
[TBL] [Abstract][Full Text] [Related]
14. Gastric and cardiac inflammatory myofibroblastic tumor: an extremely rare case.
Huang Y; Zhang M; Li Q; Huang Q
J Cardiothorac Surg; 2024 Jan; 19(1):31. PubMed ID: 38287440
[TBL] [Abstract][Full Text] [Related]
15. Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report.
Zhao C; Zhang Q; Qiao W
Medicine (Baltimore); 2017 Dec; 96(50):e9276. PubMed ID: 29390380
[TBL] [Abstract][Full Text] [Related]
16. [Exceptional bilocular inflammatory myofibroblastic pseudotumour (IMT) characterized by recurrent thoracic tumour growth and a rare (adult) second manifestation within the mesenteric tissue of the small intestine].
Petersen M; Kuester D; Roessner A; Schütte K; Lippert H; Meyer F
Z Gastroenterol; 2010 May; 48(5):555-9. PubMed ID: 20140844
[TBL] [Abstract][Full Text] [Related]
17. Uterine metastases originating from a pulmonary inflammatory myofibroblastic tumor.
Zhang J; Li Y; Lou L
J Cancer Res Ther; 2018; 14(Supplement):S257-S259. PubMed ID: 29578184
[TBL] [Abstract][Full Text] [Related]
18. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity.
Ono A; Murakami H; Serizawa M; Wakuda K; Kenmotsu H; Naito T; Taira T; Koh Y; Ohde Y; Nakajima T; Endo M; Takahashi T
Lung Cancer; 2016 Sep; 99():151-4. PubMed ID: 27565932
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.
Fu X; Jiang J; Tian XY; Li Z
Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751
[TBL] [Abstract][Full Text] [Related]
20. Core Biopsy Diagnosis of ALK Positive Inflammatory Myofibroblastic Tumor of Lung: An Interesting Case.
Sachdev R; Mohapatra I; Goel S; Ahlawat K; Sharma N
Turk Patoloji Derg; 2020; 36(2):173-177. PubMed ID: 30632123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
